title: Neoepitope Vaccines Next Immunotherapy Frontier.
abstract: Memorial Sloan Kettering Cancer Center has teamed up with biotechnology company Advaxis to explore development of neoepitope-based immunotherapies. The partnership is just one of several such ventures in a promising area of research that uses advanced sequencing technology to customize vaccines based on altered proteins in individual patients' tumors.
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D004252:DNA Mutational Analysis; D000939:Epitopes / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D057285:Precision Medicine
chemical_list: D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D000939:Epitopes